Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deoxythymidine and Deoxycytidine Treatment for Thymidine Kinase 2 (TK2) Deficiency

NCT03639701 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03639701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03639701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deoxythymidine and Deoxycytidine Treatment for Thymidine Kinase 2 (TK2) Deficiency
Lead sponsor
Columbia University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 16, 2017
Completion date
December 31, 2026
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitochondrial dna depletion syndrome 2 myopathic type, thymidine kinase 2 deficiency